Leach Jacob Steven 4
4 · DEXCOM INC · Filed Mar 14, 2025
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Leach Jacob Steven
DirectorPresident, CEO, and Director
Transactions
- Sale
Common Stock
2025-03-12$70.38/sh−14,076$990,670→ 313,497 total
Holdings
- 47,296(indirect: Family Holdings)
Common Stock
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026.
- [F3]Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.